Bristol-Myers Squibb Co v. AstraZeneca Pharmaceuticals LP

Court

District Court, D. Delaware (D. Del.)
Official Court Website →

Assigned judge

Matthew F. Kennelly · 13,571 cases in index

Docket number

1:23-cv-00079

Cause

35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement

Nature of suit

830 Patent
Infringement of a patented invention.

Jurisdiction

Federal Question

Jury demand

Plaintiff

Date filed

01/23/2023

Date terminated

07/31/2023

11,768 Patent cases in this court are indexed here.

Parties

• plaintiff · Bristol-Myers Squibb Pharmaceuticals & Biotechnology · 9426 cases
• defendant · Astrazeneca Pharmaceuticals LP · 8379 cases

Part of a Larger Litigation Pattern

This is one of 8,380 Patent cases in our index naming ASTRAZENECA PHARMACEUTICALS LP — a possible mass-tort or coordinated-litigation cluster.

• Bristol-Myers Squibb Co v. AstraZeneca Pharmaceuticals LP
  District Court, D. DelawareFiled 04/25/2023
• Bristol-Myers Squibb Co v. AstraZeneca Pharmaceuticals LP
  District Court, D. DelawareFiled 03/17/2022
• Puma Biotechnology, Inc v. AstraZeneca Pharmaceuticals LP
  District Court, D. DelawareFiled 09/22/2021
• Astrazeneca Pharmaceuticals LP v. Fresenius Kabi USA, LLC
  District Court, D. New JerseyFiled 12/14/2017
• AstraZeneca Pharmaceuticals LP v. Fresenius Kabi USA, LLC
  District Court, D. DelawareFiled 12/14/2017
• Coding Technologies, LLC v. AstraZeneca Pharmaceuticals, LP
  District Court, D. DelawareFiled 10/16/2017

About Patent Lawsuits

Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

Frequently Asked Questions

What is Bristol-Myers Squibb Co v. AstraZeneca Pharmaceuticals LP?

Bristol-Myers Squibb Co v. AstraZeneca Pharmaceuticals LP is a federal patent lawsuit filed on 01/23/2023 in the District Court, D. Delaware. The case was terminated on 07/31/2023. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What type of case is this?

It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What court is the case in?

The case is in the District Court, D. Delaware, docket number 1:23-cv-00079.

When was the case filed?

Bristol-Myers Squibb Co v. AstraZeneca Pharmaceuticals LP was filed on 01/23/2023. It was terminated on 07/31/2023.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.